Fabian Schmidt

Recordati (Ireland) — Ireland

Medicine · Health Sciences

41h-index14.8kcitations130works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(61), COVID-19 Clinical Research Studies(21), Animal Virus Infections Studies(16), SARS-CoV-2 detection and testing(14), HIV Research and Treatment(13)

Publications130 total

One-step generation of TCR knock-in mice targeted to the TCRβ locus results in functional mature T lymphocytes
2026Open Access
Cost-effectiveness of pasireotide long-acting release in acromegaly: a systematic literature review and methodology assessment
Journal of Medical Economics·2026Open Access
Cost-effectiveness of pasireotide long-acting release in acromegaly: a systematic literature review and methodology assessment
Figshare·2026Open Access
Cost-effectiveness of pasireotide long-acting release in acromegaly: a systematic literature review and methodology assessment
Figshare·2026Open Access
CO150 Indirect Treatment Comparison of Biochemical Control Between Pasireotide Long-Acting Release and Pegvisomant as Second-Line Therapies for Acromegaly, Based on Real-World Evidence
Value in Health·2025
EE379 Economic Evaluation of Dinutuximab Beta in the Maintenance Therapy of High-Risk Neuroblastoma in Brazil
Value in Health·2025
Assessing Scale and Predictive Diversity in Models for Single-Cell Transcriptomics based on Geneformer
2025Open Access
Matching-Adjusted Indirect Comparison of Osilodrostat Versus Metyrapone for the Treatment of Cushing’s Syndrome
Advances in Therapy·2025· 2 cited
PCR91 Health-Related Quality of Life of Patients With Cushing’s Disease Treated With Osilodrostat: Mixed-Effects Regression Analysis
Value in Health·2024Open Access
Comparative efficacy and safety of osilodrostat vs metyrapone for the treatment of Cushing's syndrome - a matching-adjusted indirect comparison using LINC-3 and LINC-4
Endocrine Abstracts·2024
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
mBio·2024· 31 citedOpen Access
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Nature Communications·2024· 14 citedOpen Access
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies
Proceedings of the National Academy of Sciences·2023· 4 citedOpen Access
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV
EBioMedicine·2023· 6 citedOpen Access
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
2023· 5 citedOpen Access
EE402 Cost-Effectiveness Analysis of Pasireotide Long-Acting Release As a Second Line Treatment for Adult Acromegaly Patients
Value in Health·2023· 1 citedOpen Access
Health state utility value of Cushing syndrome patients after bilateral adrenalectomy-systematic literature review and mapping to EQ-5D
Endocrine Abstracts·2023
Patients with acromegaly continue to derive clinical benefit from pasireotide long-acting release (LAR) for up to 12 years of treatment: Follow-up analysis of patients who received pasireotide during the clinical trial programme
Endocrine Abstracts·2023
Comparative Efficacy and Safety of Osilodrostat Vs Metyrapone for the Treatment of Cushing's Syndrome - a Matching-Adjusted Indirect Treatment Comparison
Endocrine Abstracts·2023· 1 cited
JoVE Video Dataset
2023
page 1 of 7Next →

Frequent Co-authors

Paul D. Bieniasz(44), Théodora Hatziioannou(42), Frauke Muecksch(37), Michel C. Nussenzweig(35), Christian Gaebler(30), Marina Caskey(30), Zijun Wang(28), Alice Cho(25), Anna Gazumyan(25), Yiska Weisblum(25), Melissa Cipolla(21), Katrina G. Millard(18), Víctor Ramos(17), Davide F. Robbiani(16), Christopher O. Barnes(16), Shlomo Finkin(16), Julio C. C. Lorenzi(15), Thiago Y. Oliveira(14), Dennis Schaefer-Babajew(14), Pamela J. Björkman(13)